BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment
BDR Pharmaceutical has launched 80mg advanced version of its Enzalutamide drug. Earlier the company had received the approval from…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.